Location History:
- Manitoba, CA (2014)
- Winnipeg, CA (2014 - 2022)
Company Filing History:
2 out of 536 
4 out of 832,961 Years Active: 2014-2022
Title: Innovations of Gary Van Domselaar
Introduction
Gary Van Domselaar is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of immunology, particularly in the development of vaccines against influenza viruses. With a total of six patents to his name, his work has the potential to impact public health significantly.
Latest Patents
One of his latest patents is focused on a synthetic hemagglutinin as a universal vaccine against infection by type B influenza viruses. This synthetic hemagglutinin (sHA) represents the highest degree of conservation in the HA sequences of all Influenza B viruses. The recombinant adenovirus carrying the sHA gene was delivered intranasally into DAB/2 mice. The results showed that the synthetic HA vaccines afforded 100% protection against lethal challenges, while significant lung viruses were found in the control group. Another patent involves reagents and methods for detecting influenza. This patent identifies two universally conserved sequences from influenza type A neuraminidases, which were chemically modified to generate mono-specific and monoclonal antibodies. These antibodies can bind to all nine subtypes of neuraminidase, demonstrating remarkable specificity against viral sequences.
Career Highlights
Throughout his career, Gary has worked with various organizations, including Her Majesty the Queen in Right of Canada, as represented by the Minister. His innovative work has led to advancements in vaccine development and detection methods for influenza viruses.
Collaborations
Gary has collaborated with notable coworkers such as Runtao He and Xuguang Li. Their combined expertise has contributed to the success of his research and patent applications.
Conclusion
Gary Van Domselaar's contributions to vaccine development and influenza detection methods highlight his importance as an inventor in the field of immunology. His innovative patents have the potential to enhance public health and provide new solutions to combat influenza viruses.